Australia's Lumos Diagnostics rises on obtaining $1.3 million purchase order

Lumos Diagnostics Holdings

01/04/2026 02:27

** Shares of Lumos Diagnostics LDX.AX up 9.1% at A$0.24, set for their strongest session since March 11, if current trends hold

** The diagnostic firm receives its largest FebriDx purchase order to date from PHASE Scientific

** Purchase order valued at $1.3 million, adds company

** LDX stock down 15.8% this year, including the day's move

 (Reporting by Sherin Sunny in Bengaluru)

 ((Sherin.Sunny@thomsonreuters.com))